ClinicalTrials.gg
RecruitingNCT06146270RuSOSUpdated Apr 4, 2025

Russian Registry of Surgical OutcomeS

An observational study in Surgery, Anesthesia and Outcome, Fatal, sponsored by Russian Federation of Anesthesiologists and Reanimatologists. Recruiting at 16 sites in Russian Federation. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-04.

Sponsored by Russian Federation of Anesthesiologists and Reanimatologists · Observational

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
162,000
Ages
18 Years and older
Sex
All
01

Study summary

Identification of risk factors that cause a high probability of an unfavorable outcome in the postoperative period is an urgent problem. The creation of national databases (registries) makes it possible to maximally cover a certain patient population by identifying its characteristic risk predictors. As literature data show, existing registries differ in the criteria for inclusion in the study, in the characteristics of the populations studied, and there is often no common view on the classification of postoperative outcomes. Goal of a study is a creation of a Russian national calculator for the risk of postoperative complications and mortality.

Two-level observational retrospective-prospective study was planned. Setting: National multicenter study of surgical inpatients. Patients: Adult patients undergoing elective and emergency surgery. Types of interventions: in obstetrics, in gynecology, on the breast, in urology and kidneys, in endocrine surgery, in maxillofacial surgery, in orthopedics and traumatology, on the lower floor of the abdominal cavity, on the liver and biliary tract, on the upper floor of the abdominal cavity cavities, in thoracic surgery, in vascular surgery, in neurosurgery, in cardiac surgery, in other areas (with mandatory specification).

The study was organized by the Federation of Anesthesiologists and Reanimatologists of Russia. Primary (30-day mortality, 30-day complications) and secondary (hospital mortality, hospital complications, length of stay in anesthesiology, resuscitation and intensive care departments, length of hospital stay, multiple organ failure (2 or more points on the SOFA scale (Sequential)) Organ Failure Assessment), 90-day mortality, 90-day complications, intensive care after-effects syndrome, readmission, 1-year mortality) outcomes were determined. The required sample size and statistical analysis methods are described. The planned duration of the study is 2024-2028.

Read the detailed description

Currently, the incidence of perioperative complications and mortality associated with surgical intervention are minimized. However, taking into account the significant number of surgical interventions performed worldwide (more than 300 million per year), the total number of patients with complicated postoperative periods is large, and postoperative mortality ranks third in the structure of causes of death (7, 7%), second only to coronary heart disease and stroke. Moreover, even in discharged patients, complications that develop can significantly reduce quality of life and worsen long-term prognosis. To a greater extent, the above applies to high-risk patients, whose identification is a priority task of anesthesiology.

Identification of risk factors that cause a high probability of an unfavorable outcome is currently unthinkable without conducting comprehensive prospective population-based studies, which, on the one hand, make it possible to assess the contribution of many variables to the risk of complications and mortality, and on the other hand, to maximally cover a certain population by identifying characteristic predictors for it. To date, several population-based studies and programs have been described in the literature that have led to the creation of national databases (registries) of postoperative outcomes. Such studies include several international (ISOS, EuSOS and ASOS) and national ones, such as SweSOS [8] or ColSOS , which are at different stages of implementation. Among the national databases, the best known is the ACS-NSQIP (American College of Surgeons National Surgical Quality Improvement Program) database, which contains information on the outcomes of surgical treatment for more than 5 million patients in the United States since 1991 .

The results obtained from these studies often vary widely, due to the diversity of approaches to study inclusion criteria, differences in the characteristics of the populations studied, and the lack of a uniform view on the classification of postoperative outcomes. When assessing mortality, the authors most often record 30-day mortality, however, taking into account modern ideas about the role of perioperative factors and complications in the development of an unfavorable long-term outcome, the need to determine one-year mortality becomes obvious. As shown by the national observational study SweSOS, the mortality rate increases significantly over time, with 30-day mortality being 1.8%, 3-month mortality - 3.9%, and 6-month and annual mortality - 5.0% and 8.5% , respectively .

There is also no uniform approach to the registration of postoperative complications, and modern protocols use several systems, the most common of which are the classification of the joint working group of ESA (The European Society of Anesthesiologists) and ESICM (The European Society of Intensive Care Medicine, The European). Society of Intensive Care Medicine) and the ACS-NSQIP classification (The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP)). And although they are similar in many ways (complications are grouped into blocks according to the nature of the disorders), differences are also present, and even the same complication may have a different definition. In addition, some significant outcomes are not included in these classifications, which predetermines their underestimation.

Of course, one of the advantages of creating a large population-based database is the recording of a large number of potential predictors of adverse outcome and subsequent assessment of their individual contribution to the complex perioperative risk. The type of surgical intervention itself is a factor that largely determines the likelihood of complications.

The goal is to create a Russian national calculator for the risk of postoperative complications and mortality.

Primary target points:

  1. Creation of a national register of postoperative outcomes in different areas of surgery.
  2. Determination of the frequency and structure of outcomes after elective and emergency surgery.
  3. Identification of predictors of unfavorable outcome.
  4. Development and validation of a model for predicting complications and mortality in various areas of surgery
  5. Creation of calculators for the risk of postoperative complications and mortality in various fields of surgery and their integration into a single calculator
  6. Analysis of long-term results in patients with postoperative complications (90 days and a year after surgery)

Secondary target points:

  1. The role of concomitant diseases in the development of unfavorable outcome
  2. The influence of age on primary and secondary postoperative outcomes
  3. The influence of the type of anesthesia on the course of the postoperative period
  4. The influence of oncological pathology and specific treatment on primary and secondary postoperative outcomes
  5. The impact of the urgency of surgery on the risk of an unfavorable outcome
  6. Influence of localization, access and duration of surgery on postoperative outcome
  7. Assessment and validation of surgical and anesthesiological risk scales for lethal outcome (can be listed)
  8. Evaluation and validation of surgical and anesthetic risk scales for primary and secondary outcomes
  9. Stratification of patients at high perioperative risk with details on cardiac, respiratory, neurological, renal, hepatic, hemostasiological, infectious and others.
  10. Influence of quality criteria for implementation of FAR recommendations on the course of the postoperative period
  11. Analysis of the course of ICU-syndrome in patients with complications and depending on the maximum score on the SOFA scale and the structure of MOF in the postoperative period
  12. Analysis of the effectiveness of rehabilitation measures in patients with ICU-syndrome
  13. Analysis of the causes of mortality (based on autopsy reports and clinical and laboratory data of patients).

Cohort A

The checklist (basic) is filled out for all patients with postoperative complications. At the same time, the total number of patients operated on in a particular center is taken into account on a quarterly basis, taking into account their distribution by area of surgery. Based on the data from the basic checklist, answers will be received to the following target points:

  1. Creation of a national register of postoperative outcomes in different areas of surgery.
  2. Determination of the frequency and structure of outcomes after planned and emergency surgical interventions.
  3. Analysis of long-term results in patients with postoperative complications (90 days and a year after surgery)
  4. Analysis of the course of ICU-syndrome in patients with complications and depending on the maximum score on the scale and the structure of MOF in the postoperative period
  5. Analysis of the effectiveness of rehabilitation measures in patients with ICU syndrome

Cohort B Basic checklist plus additional checklist: completed for all operated patients within one selected week quarterly The total number of patients operated on in a particular center is also taken into account quarterly, taking into account their distribution by area of surgery.

Based on the data from the basic and additional checklists, answers to the most important target points (3 primary and 10 secondary) will be obtained:

  1. Identification of predictors of unfavorable outcome.
  2. Development and validation of a model for predicting complications and mortality in various fields of surgery
  3. Creation of calculators for the risk of postoperative complications and mortality in various fields of surgery and their integration into a single calculator
  4. The role of concomitant diseases in the development of unfavorable outcome
  5. The influence of age on primary and secondary postoperative outcomes
  6. The influence of the type of anesthesia on the course of the postoperative period
  7. The influence of oncological pathology and specific treatment on primary and secondary postoperative outcomes
  8. The impact of the urgency of surgery on the risk of an unfavorable outcome
  9. The influence of localization, access and duration of surgery on postoperative outcome
  10. Assessment and validation of surgical and anesthesiological risk scales for lethal outcome (can be listed)
  11. Evaluation and validation of surgical and anesthetic risk scales for primary and secondary outcomes
  12. Stratification of patients at high perioperative risk with details on cardiac, respiratory, neurological, renal, hepatic, hemostasiological, infectious and others.
  13. Influence of quality criteria for implementation of FAR recommendations on the course of the postoperative period
02

Conditions studied

  • Surgery
  • Anesthesia
  • Outcome, Fatal
  • Complication
03

In context

Lead sponsor

Russian Federation of Anesthesiologists and Reanimatologists is the lead sponsor of 6 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients undergoing surgery in various areas of surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (age 18 years and older) undergoing elective surgery:

    • In obstetrics
    • In gynecology
    • Breast
    • In urology and kidneys
    • In endocrine surgery
    • In maxillofacial surgery
    • In orthopedics and traumatology
    • On the lower abdominal cavity
    • On the liver and biliary tract
    • On the upper abdominal cavity
    • In thoracic surgery
    • In vascular surgery
    • In neurosurgery
    • In cardiac surgery
    • In other areas (with mandatory specification)
  • Adult patients (age 18 years and older) undergoing emergency surgery in the listed and other areas of surgery (for example, in purulent surgery).

Exclusion criteria

Exclusion Criteria:

  1. Lack of from the patient
  2. Complications associated with the manipulations of an anesthesiologist
  3. Interventions without the participation of an anesthesiologist-resuscitator
  4. Incomplete checklists
  5. Errors when filling checklists
  6. Deviations from the Register protocol
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
162,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Cohort A

    A cohort in which the incidence of the primary outcomes in the study population will be assessed.

  • Cohort B

    A cohort in which risk factors for primary outcomes will be identified, and a risk calculator for their development will be developed and validated

06

What researchers measure

Primary outcomes

  1. Postoperative mortality

    Incidence of postoperative death defined as any death occurring during and up to 30 days after surgery

    Time frame: up to 30 days after surgery

  2. Postoperative complications

    Incidence of the following complications with severity due to Clavien-Dindo classification: Arrhythmia Cardiac arrest Cardiogenic pulmonary edema Deep vein thrombosis Myocardial infarction Myocardial damage after non-cardiac operations Pulmonary embolism Postoperative transfusion Postoperative delirium Stroke ARDS Acute respiratory failure Pneumonia Pleural effusion Atelectasis Respiratory infection Bronchospasm Pneumothorax Aspiration pneumonitis Reintubation Renal injury Infection without a specific source Laboratory confirmed bacteremia Superficial wound infection Deep wound infection Postoperative infection Urinary tract infection Sepsis Septic shock Gastrointestinal bleeding Paralytic ileus Postoperative bleeding Anastomotic leakage Dehiscence of wound Other Malignant hyperthermia Anaphylaxis Anaphylactic shock Fat embolism

    Time frame: up to 30 days after surgery

Secondary outcomes

  1. Length of stay in the ICU

    Number of days in the ICU

    Time frame: up to 30 days after surgery

  2. Length of hospital stay

    Number of days in the hospital

    Time frame: up to 30 days after surgery

  3. Multiple organ failure (2 or more points on the SOFA (Sequential Organ Failure Assessment) scale)

    Incidence of MOF

    Time frame: up to 30 days after surgery

  4. 90-days mortality

    Incidence of postoperative death defined as any death occurring during and up to 90 days after anaesthesia

    Time frame: up to 90 days after surgery

  5. 90-days postoperative complications

    Incidence of the following complications with severity due to Clavien-Dindo classification: Arrhythmia Cardiac arrest Cardiogenic pulmonary edema Deep vein thrombosis Myocardial infarction Myocardial damage after non-cardiac operations PE Postoperative transfusion Postoperative delirium Stroke ARDS Acute respiratory failure Pneumonia Pleural effusion Atelectasis Respiratory infection Bronchospasm Pneumothorax Aspiration pneumonitis Reintubation Renal injury Infection without a specific source Laboratory confirmed bacteremia Superficial wound infection Deep wound infection Postoperative infection Urinary tract infection Sepsis Septic shock Gastrointestinal bleeding Paralytic ileus Postoperative bleeding Anastomotic leakage Dehiscence of wound Other Malignant hyperthermia Anaphylaxis Anaphylactic shock Fat embolism

    Time frame: up to 90 days after surgery

  6. ICU - syndrome

    The intensive care unit (ICU) syndrome is a type of organic brain syndrome manifested by a variety of psychological reactions, including fear, anxiety, depression, hallucinations, and delirium.

    Time frame: up to 90 days after surgery

  7. Readmission

    Any readmission to the hospital

    Time frame: up to 1 year after surgery

  8. 1-year mortality

    Incidence of death defined as any death occurring during and up to 1 year after surgery

    Time frame: up to 1 year after surgery

07

Study locations

11 of 16 sites recruiting
  • The First City Clinical Hospital. n.a. E. E. Volosevich
    Arkhangel'sk, Russian Federation
    Recruiting
    • Mikhail Kirov, MD · Contact
    • Mikhail Kirov, MD · Principal investigator
  • Clinical city hospital № 40
    Ekaterinburg, Russian Federation
    Recruiting
    • Andrey Belkin, MD · Contact
    • Andrey Belkin, MD · Principal investigator
  • Kuzbass Clinical Emergency Hospital named after M.A. Podgorbunsky
    Kemerovo, Russian Federation
    Recruiting
    • Evgeny Grigoriev · Contact
    • Evgeny Grigoriev, MD · Principal investigator
  • Regional clinical hospital №2
    Krasnodar, 350012, Russian Federation
    Recruiting
    • Nikita Trembach, PhD · Contactnikitkax@mail.ru
    • Nikita Trembach, PhD · Principal investigator
  • Kuban State Medical University
    Krasnodar, 350063, Russian Federation
    Recruiting
    • Igor Zabolotskikh · Contactpobeda_zib@mail.ru
    • Igor Zabolotskikh, MD · Principal investigator
  • Krasnodar regional hospital №2 (Kuban State Medical University)
    Krasnodar, Russian Federation
    Not yet recruiting
    • Igor Zabolotskikh, MD · Contact
    • Igor Zabolotskikh, MD · Principal investigator
  • Regional clinical hospital
    Krasnoyarsk, Russian Federation
    Recruiting
    • Alexey Gritsan · Contact
    • Alexey Gritsan, MD · Principal investigator
  • Federal research and clinical center of intensive care medicine and rehabilitology
    Moscow, Russian Federation
    Recruiting
    • Artem Kuzovlev · Contact
    • Kuzovlev Kuzovlev, MD · Principal investigator
  • Loginov Moscow Clinical Scientific Center
    Moscow, Russian Federation
    Not yet recruiting
    • Valeriy Subbotin, MD · Contact
    • Valeriy Subbotin, MD · Principal investigator
  • Military Medical Academy
    Moscow, Russian Federation
    Not yet recruiting
    • Alexey Shchegolev, MD · Contact
    • Alexey Shchegolev, MD · Principal investigator
  • Moscow cancer research Institute named after P. A. Herzen
    Moscow, Russian Federation
    Recruiting
  • Moscow Regional Research and Clinical Institute, Moscow, Russia
    Moscow, Russian Federation
    Not yet recruiting
    • Efim Shifman, MD · Contact
    • Efim Shifman, MD · Principal investigator
  • Moscow regional research clinical Institute named after M. F. Vladimirsky
    Moscow, Russian Federation
    Recruiting
    • Alexey Ovezov, MD · Contactamolex@mail.ru
    • Alexey Ovezov, MD · Principal investigator
  • Orenburg City N.I. Pirogov Clinical Hospital
    Orenburg, Russian Federation
    Recruiting
    • Vadim Ershov · Contact
    • Vadim Ershov, MD · Principal investigator
  • North-Western State Medical University named after Ilya I. Mechnikov,
    Saint Petersburg, Russian Federation
    Not yet recruiting
    • Konstantin Lebedinsii, MD · Contact
    • Konstantin Lebedinsii, MD · Principal investigator
  • Regional clinical hospital №2
    Vladivostok, Russian Federation
    Recruiting
    • Pavel Dunts, PhD · Contactdpv@bk.ru
    • Pavel Dunts, PhD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Dec 2028, 47 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2023
First posted
Nov 24, 2023
StartActual
Jan 9, 2025
Primary completionEst.
Dec 31, 2028
CompletionEst.
Jan 31, 2029
Last update
Apr 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06146270
Lead sponsor
Russian Federation of Anesthesiologists and Reanimatologists
Collaborators
Kuban State Medical University
Responsible party
Sponsor
First posted
Nov 24, 2023
Start date
Jan 9, 2025
Primary completion
Dec 31, 2028 (estimated)
Completion
Jan 31, 2029 (estimated)
Last update
Apr 4, 2025

Study contacts

Igor Zabolotskikh, MD
Contact
pobeda_zib@mail.ru
+79183883499
Igor Zabolotskikh, MD
study chair · Kuban State Medical University
Nikita Trembach, MD
study director · Kuban State Medical University
Andrey Belkin, MD
study director · Clinical Institute of Brain
Evgeniy Grigiriev, MD
study director · Research Institute for Complex Issues of Cardiovascular Diseases
Alexei Gritsan, MD
study director · Voino-Yasenetsky Krasnoyarsk State Medical University
Pavel Dunts, PhD
study director · Pacific State Medical University
Vadim Ershov, MD
study director · Orenburg State Medical University
Mikhail Kirov, MD
study director · Northern State Medical University
Artem Kuzovlev, MD
study director · Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
Alexandr Kulikov, MD
study director · Ural State Medical University
Alexey Ovezov, MD
study director · Moscow Regional Research and Clinical Institute
Denis Protsenko, MD
study director · Pirogov Russian National Research Medical University
Valeriy Subbotin, MD
study director · Loginov Moscow Clinical Scientific Center
Victoria Khoronenko, MD
study director · P. A. Hertsen Moscow Oncology Research Center
Efim Shifman, MD
study director · Moscow Regional Research and Clinical Institute, Moscow, Russia
Alexey Shchegolev, MD
study director · Military Medical Academy, Bulgaria
Konstantin Lebedinskii, MD
study director · North-Western State Medical University named after Ilya I. Mechnikov

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion